1 |
Short-Term Adverse Drug Reactions to Antiretroviral Therapy in Children with HIV: A Cohort Study |
|
|
| Sandip Ray, Anju Seth, Sarita Singh, Garima Sharma, Neha Gaur, Yukti Shah, Praveen Kumar, Jagdish Chandra |
|
| Indian Journal of Pediatrics. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
2 |
Adverse drug reaction patterns of anti-retroviral drugs: A study in a tertiary care teaching Institute of north east India |
|
|
| CHRISTINA ZOSANGPUII, SWAGATA DATTA, NGANGOM GUNINDRO, DN MEENA, SURJIT SINGH NAMEIRAKPAM |
|
| Asian Journal of Pharmaceutical and Clinical Research. 2022; : 38 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
3 |
Treatment outcome of different antiretroviral drug regimens in HIV-positive pregnant women |
|
|
| Nidhi Chauhan,Mira Desai,Samidh Shah,Asha Shah,Rajendra Gadhavi |
|
| Perspectives in Clinical Research. 2021; 12(1): 40 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
4 |
Annual Costs Incurred in Managing Adverse Drug Reactions Attributable to Fixed-Dose Combination Highly Active Antiretroviral Therapy in an Outpatient Antiretroviral Clinic in Gauteng: A Budget Impact Analysis |
|
|
| Grace Chikeya,Frasia Oosthuizen,Varsha Bangalee |
|
| Value in Health Regional Issues. 2021; 25: 142 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
5 |
Neuropsychiatric Effects of Antiviral Drugs |
|
|
| Nicholas Zareifopoulos,Maria Lagadinou,Anastasia Karela,Ourania Kyriakopoulou,Dimitrios Velissaris |
|
| Cureus. 2020; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
6 |
Nature and prevalence of adverse drug reaction of antiretroviral medications in Halibet National Referral Hospital: a retrospective study |
|
|
| Lidya Hagos,Siyoma Fessehaye,Indermeet Singh Anand |
|
| BMC Pharmacology and Toxicology. 2019; 20(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
7 |
Pharmacovigilance in perspective: drug withdrawals, data mining and policy implications |
|
|
| Muaed Alomar,Subish Palaian,Moawia M. Al-tabakha |
|
| F1000Research. 2019; 8: 2109 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
8 |
A Retrospective Review of Serious Adverse Drug Reaction Reports in the Nigerian VigiFlow Database from September 2004 to December 2016 |
|
|
| Comfort Kunak Ogar,Abiodun Abiola,Daniel Yuah,Ali Ibrahim,Ibrahim Adekunle Oreagba,Emmanuel C. Amadi,Mojisola Christianah Adeyeye,Kazeem Adeola Oshikoya |
|
| Pharmaceutical Medicine. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
9 |
The life-threatening eruption in HIV and immunosuppression |
|
|
| Marcia Ramos-e-Silva,Pedro Secchin,Beatriz Trope |
|
| Clinics in Dermatology. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
10 |
Named entity recognition from Chinese adverse drug event reports with lexical feature based BiLSTM-CRF and tri-training |
|
|
| Yao Chen,Changjiang Zhou,Tianxin Li,Hong Wu,Xia Zhao,Kai Ye,Jun Liao |
|
| Journal of Biomedical Informatics. 2019; 96: 103252 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
11 |
The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database |
|
|
| Genaro Castillon,Francesco Salvo,Yola Moride |
|
| Drug Safety. 2018; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
12 |
Patterns of adverse drug reaction signals in NAFDAC pharmacovigilance activities from January to June 2015: safety of drug use in Nigeria |
|
|
| Olufunsho Awodele,Rebecca Aliu,Ibrahim Ali,Yetunde Oni,Christianah Mojisola Adeyeye |
|
| Pharmacology Research & Perspectives. 2018; 6(5): e00427 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
13 |
Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: A prospective cohort study |
|
|
| Yohanna Kambai Avong,Bolajoko Jatau,Ritmwa Gurumnaan,Nanfwang Danat,James Okuma,Istifanus Usman,Dennis Mordi,Blessing Ukpabi,Gbenga Ayodele Kayode,Saswata Dutt,Osman El-Tayeb,Bamgboye Afolabi,Isah Ambrose,Oche Agbaji,Adeline Osakwe,Ali Ibrahim,Comfort Ogar,Helga Nosiri,Eunice B. Avong,Victor Adekanmbi,Olalekan Uthman,Alash’le Abimiku,Yetunde O. Oni,Charles Olalekan Mensah,Patrick Dakum,Kamau Edward Mberu,Olumide A. T. Ogundahunsi,Albert Figueras |
|
| PLOS ONE. 2018; 13(8): e0200810 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
14 |
Prevalence and Clinical Profile of Drug Eruptions among Antiretroviral Therapy-Exposed HIV Infected People in Yaoundé, Cameroon |
|
|
| Emmanuel Armand Kouotou,Jobert Richie Nansseu,Vanessa Nancy Ngono,Sandra A. Tatah,Anne Cecile Zoung-Kanyi Bissek,Elie Claude Ndjitoyap Ndam |
|
| Dermatology Research and Practice. 2017; 2017: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
15 |
Sentinel site active surveillance of safety of first-line antiretroviral medicines in Namibia |
|
|
| Marita Mann,Assegid Mengistu,Johannes Gaeseb,Evans Sagwa,Greatjoy Mazibuko,Jared M. Baeten,Joseph B. Babigumira,Louis P. Garrison,Andy Stergachis |
|
| Pharmacoepidemiology and Drug Safety. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
16 |
Pharmacovigilance in Nigeria: An Overview |
|
|
| Abimbola Olowofela,Annie Fourrier-Réglat,Ambrose O. Isah |
|
| Pharmaceutical Medicine. 2016; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
17 |
Patterns of adverse drug reaction signals in NAFDAC Pharmacovigilance activities from September to November, 2014 |
|
|
| Olufunsho Awodele,Ali Ibrahim,Paul Orhii |
|
| International Journal of Risk & Safety in Medicine. 2016; 28(1): 13 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
18 |
Influence of Adverse Drug Reactions on Treatment Success: Prospective Cohort Analysis of HIV-Infected Individuals Initiating First-Line Antiretroviral Therapy in India |
|
|
| Anita Shet,Jimmy Antony,Karthika Arumugam,Sunil Kumar Dodderi,Rashmi Rodrigues,Ayesha DeCosta,Wenzhe Ho |
|
| PLoS ONE. 2014; 9(3): e91028 |
|
| [Pubmed] [Google Scholar] [DOI] |
|